Vancomycin Dosing and AUC Monitoring: A Reference
A reference explanation of how vancomycin dosing works — why AUC-guided monitoring replaced trough targets, what pharmacokinetic parameters drive the calculation, and why levels rather than formulas determine the dose.
This page explains the principles behind vancomycin dosing. It produces no dose. Vancomycin requires therapeutic drug monitoring with measured serum concentrations, and dosing should be managed by clinical pharmacy or an infectious diseases service using validated pharmacokinetic software.
Formula & Reference
| Variable | Symbol | Formula | Units |
|---|---|---|---|
| Vancomycin Dosing and AUC Monitoring: A Reference | — | Concept reference — no dose output | concept |
Step-by-Step Examples
It has a narrow therapeutic index — the gap between effective and toxic is small.
- Subtherapeutic exposure risks treatment failure and resistance selection
- Excessive exposure causes nephrotoxicity, the dose-limiting harm
- Clearance tracks renal function, which changes during serious infection
- Volume of distribution varies with fluid status, obesity, and critical illness
- No formula predicts an individual's exposure accurately enough to skip measurement
Guidelines moved away from trough-only monitoring for a specific reason.
- The pharmacodynamic target is the ratio of area under the curve to MIC, conventionally around 400–600
- Troughs were used historically as a convenient surrogate for AUC
- Trough targets of 15–20 mg/L were found to increase nephrotoxicity without improving outcomes
- Current consensus guidance recommends AUC-guided dosing
- AUC estimation uses either two-level pharmacokinetic calculation or Bayesian software
AUC-guided dosing is not arithmetic that generalises.
- Bayesian dose optimisation software incorporates population models and individual levels
- Estimates update as each measured concentration arrives
- Renal function during sepsis can change substantially day to day
- Augmented renal clearance in younger critically ill patients causes systematic underdosing
- Most hospitals run this through clinical pharmacy services for exactly these reasons
Real-World Applications
Common Mistakes to Avoid
Consensus guidance moved to AUC-guided dosing because higher trough targets increased acute kidney injury without demonstrable benefit. Trough-only monitoring is no longer the recommended approach for serious MRSA infection.
In sepsis, renal function can shift dramatically within a day. A dose calculated on admission creatinine may be badly wrong forty-eight hours later.
Because vancomycin takes time to reach target concentrations, seriously ill patients are often underexposed early unless a loading dose is given.